NEURO-ENDOCRINE DIFFERENTIATION - A PROGNOSTIC FEATURE OF NON-SMALL-CELL LUNG-CANCER

被引：9

作者：

BAYLIN, SB

机构：

来源：

JOURNAL OF CLINICAL ONCOLOGY | 1989年 / 7卷 / 10期

关键词：

D O I：

10.1200/JCO.1989.7.10.1375

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：1375 / 1376

页数：2

共 9 条

[1]

BAYLIN SB, 1980, CANCER RES, V40, P1990

[2] VARIABLE CONTENT OF HISTAMINASE, L-DOPA DECARBOXYLASE AND CALCITONIN IN SMALL-CELL CARCINOMA OF LUNG - BIOLOGIC AND CLINICAL IMPLICATIONS [J].

BAYLIN, SB ;

WEISBURGER, WR ;

EGGLESTON, JC ;

MENDELSOHN, G ;

BEAVEN, MA ;

ABELOFF, MD ;

ETTINGER, DS .

NEW ENGLAND JOURNAL OF MEDICINE, 1978, 299 (03) :105-110

[3] ENDOCRINE-RELATED BIOCHEMISTRY IN THE SPECTRUM OF HUMAN-LUNG CARCINOMA [J].

BERGER, CL ;

GOODWIN, G ;

MENDELSOHN, G ;

EGGLESTON, JC ;

ABELOFF, MD ;

AISNER, S ;

BAYLIN, SB .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1981, 53 (02) :422-429

[4]

CARNEY DN, 1985, CANCER RES, V45, P2913

[5]

FALCO J, 1989, Proceedings of the American Association for Cancer Research Annual Meeting, V30, P438

[6]

GAZDAR AF, 1985, CANCER RES, V45, P2924

[7] THE USE OF NEURO-ENDOCRINE IMMUNOPEROXIDASE MARKERS TO PREDICT CHEMOTHERAPY RESPONSE IN PATIENTS WITH NON-SMALL-CELL LUNG-CANCER [J].

GRAZIANO, SL ;

MAZID, R ;

NEWMAN, N ;

TATUM, A ;

OLER, A ;

MORTIMER, JA ;

GULLO, JJ ;

DIFINO, SM ;

SCALZO, AJ .

JOURNAL OF CLINICAL ONCOLOGY, 1989, 7 (10) :1398-1406

[8] V-HA-RAS ONCOGENE INSERTION - A MODEL FOR TUMOR PROGRESSION OF HUMAN SMALL CELL LUNG-CANCER [J].

MABRY, M ;

NAKAGAWA, T ;

NELKIN, BD ;

MCDOWELL, E ;

GESELL, M ;

EGGLESTON, JC ;

CASERO, RA ;

BAYLIN, SB .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (17) :6523-6527

[9]

MULSHINE J, 1987, P AM ASS CLIN ONCOL, V6, P181

← 1 →